We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Illustration

Quest Diagnostics’ SARS-CoV-2 rRT-PCR Test Becomes First COVID-19 Diagnostic Test to Receive FDA EUA for Sample Pooling

The US Food and Drug Administration has reissued an emergency use authorization (EUA) to Quest Diagnostics (Secaucus, NJ, USA) to authorize its Quest SARS-CoV-2 rRT-PCR test for use with pooled samples. More...
20 Jul 2020
Image: Oxford University’s Rapid COVID-19 Test Detects SARS-CoV-2 Within 30-45 Minutes (Photo courtesy of University of Oxford)

Oxford University’s Rapid COVID-19 Test Detects SARS-CoV-2 Within 30-45 Minutes

Scientists have developed a rapid test which detects the presence of the SARS-CoV-2 virus and could be adapted for use in settings ranging from community care, schools, airports or home self-testing. More...
17 Jul 2020
Image: BD Veritor Plus System for Rapid Detection of SARS-CoV-2 (Photo courtesy of Becton, Dickinson and Company)

BD’s Point-of-Care COVID-19 Tests and Instruments to Help US Government Increase Testing Capacity

The US Department of Health and Human Services (HHS) has committed to purchase 2,000 BD Veritor Plus Systems and 750,000 SARS-CoV-2 antigen test kits for use on the system from Becton, Dickinson and Company (BD Franklin Lakes, NJ, USA). More...
16 Jul 2020
Illustration

First-in-Class COVID-19 Rapid Diagnostic Test for Neutralizing Antibodies Could Serve as Immunity Passport for Vaccine Developers

A new rapid diagnostic test for measuring levels of functional neutralizing antibodies that are believed to prevent SARS-CoV-2 from entering the host cells could serve as an ‘Immunity Passport’ for vaccine developers around the world as they begin larger Phase II and III clinical trials. More...
16 Jul 2020
Illustration

BioMérieux’s BIOFIRE Respiratory Panel 2.1 Plus with SARS-CoV-2 Receives CE Mark

BioMérieux’s (Marcy-l'Étoile, France) BIOFIRE Respiratory Panel 2.1 plus (RP2.1plus) is CE marked and will be commercially available in all countries that recognize CE marking. More...
16 Jul 2020
Illustration

Metagenomics to Help Develop Targeted Respiratory Pathogen Panel for Identifying SARS-CoV-2 and 250 Other Pathogens

Metagenomics analysis is transforming highly sophisticated research-only laboratory tools into practical diagnostics tools for routine hospital use, such as allowing physicians to determine whether a patient has COVID-19 and use the same test to confirm whether that patient has other respiratory pathogens exacerbating the illness. More...
16 Jul 2020
Image: 3M and MIT Researchers Developing Low-Cost COVID-19 Diagnostic Test that Delivers Highly Accurate Results in Minutes (Photo courtesy of 3M)

3M and MIT Researchers Developing Low-Cost COVID-19 Diagnostic Test that Delivers Highly Accurate Results in Minutes

3M (St. Paul, MN, USA) and researchers at MIT (Cambridge, MA, USA) are testing a new rapid COVID-19 test that detects the novel coronavirus. More...
15 Jul 2020
New
Gold Member
ANA & ENA Screening Assays
ANA and ENA Assays
Automated Blood Typing System
IH-500 NEXT
New
Herpes Virus Test
Human Herpes Virus (HHV-6) Real Time PCR Kit
New
Auto-Chemistry Analyzer
CS-1200
Copyright © 2000-2024 Globetech Media. All rights reserved.